Cathie Wood Dumps Tech Stocks for Gene-Editing Plays in CRISPR and Beam - Blockonomi

Cathie Wood’s ARK Invest purchased $10.06 million worth of CRISPR Therapeutics shares and $7.06 million in Beam Therapeutics stock on November 4, 2025. • ARK reduced technology holdings by selling $5.... [3335 symbols]

Últimos artigos